Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2012, Article ID 978930, 27 pages
http://dx.doi.org/10.1155/2012/978930
Review Article

Current Understanding of Lifestyle and Environmental Factors and Risk of Non-Hodgkin Lymphoma: An Epidemiological Update

1Division of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06510, USA
2Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA

Received 24 May 2012; Revised 20 July 2012; Accepted 4 August 2012

Academic Editor: P. Vineis

Copyright © 2012 Bryan A. Bassig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Morton, S. S. Wang, W. Cozen et al., “Etiologic heterogeneity among non-Hodgkin lymphoma subtypes,” Blood, vol. 112, no. 13, pp. 5150–5160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. H. Ferlay, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 10 [Internet]. Lyon, France, International Agency for Research on Cancer, 2010, http://globocan.iarc.fr/.
  3. N. Howlander, A. M. Noone, M. Krapcho et al., “SEER Cancer Statistics Review, 1975–2009,” National Cancer Institute, Bethesda, Md, USA, based on November 2011 SEER data submission, posted to the SEER web site, 2012, http://seer.cancer.gov/csr/1975_2009_pops09/.
  4. C. A. Clarke and S. L. Glaser, “Changing incidence of non-Hodgkin lymphomas in the United States,” Cancer, vol. 94, no. 7, pp. 2015–2023, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. P. H. Levine and R. Hoover, “The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors,” Cancer Epidemiology, Biomarkers & Prevention, vol. 1, no. 6, pp. 515–517, 1992. View at Google Scholar · View at Scopus
  6. P. Boffetta, B. Armstrong, M. Linet, C. Kasten, W. Cozen, and P. Hartge, “Consortia in cancer epidemiology: lessons from InterLymph,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 2, pp. 197–199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Morton, J. J. Turner, J. R. Cerhan et al., “Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph),” Blood, vol. 110, no. 2, pp. 695–708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Nelson, A. M. Levine, G. Marks, and L. Bernstein, “Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma,” British Journal of Cancer, vol. 76, no. 11, pp. 1532–1537, 1997. View at Google Scholar · View at Scopus
  9. E. V. Willett, A. G. Smith, G. J. Dovey, G. J. Morgan, J. Parker, and E. Roman, “Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma,” Cancer Causes and Control, vol. 15, no. 8, pp. 771–780, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Casey, K. Piazzon-Fevre, N. Raverdy et al., “Case-control study of lymphoid neoplasm in three French areas: description, alcohol and tobacco consumption,” European Journal of Cancer Prevention, vol. 16, no. 2, pp. 142–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Nieters, S. Rohrmann, N. Becker et al., “Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition,” American Journal of Epidemiology, vol. 167, no. 9, pp. 1081–1089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Fernberg, A. Odenbro, R. Bellocco, P. Boffetta, Y. Pawitan Y, and J. Adami, “Tobacco use, body mass index and the risk of malignant lymphomas—a nationwide cohort study in Sweden,” International Journal of Cancer, vol. 118, no. 9, pp. 2298–2302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Schollkopf, K. E. Smedby, H. Hjalgrim et al., “Cigarette smoking and risk of non-Hodgkin's lymphoma—a population-based case-control study,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 7, pp. 1791–1796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. M. Morton, T. R. Holford, B. Leaderer et al., “Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women,” British Journal of Cancer, vol. 89, no. 11, pp. 2087–2092, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Morton, P. Hartge, T. R. Holford et al., “Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph),” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 4, pp. 925–933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Parker, J. R. Cerhan, F. Dick et al., “Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women,” Leukemia and Lymphoma, vol. 37, no. 3-4, pp. 341–349, 2000. View at Google Scholar · View at Scopus
  17. H. Besson, P. Brennan, N. Becker et al., “Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: a European multicenter case-control study (Epilymph),” International Journal of Cancer, vol. 119, no. 4, pp. 901–908, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. J. Herrinton and G. D. Friedman, “Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes,” Cancer Epidemiology Biomarkers and Prevention, vol. 7, no. 1, pp. 25–28, 1998. View at Google Scholar · View at Scopus
  19. Y. Lu, S. S. Wang et al., “Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study,” American Journal of Epidemiology, vol. 174, pp. 563–573, 2011. View at Google Scholar
  20. J. D. Troy, P. Hartge, J. L. Weissfeld et al., “Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the prostate, lung, colorectal, and ovarian cancer screening trial,” American Journal of Epidemiology, vol. 171, no. 12, pp. 1270–1281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Lim, L. M. Morton, A. F. Subar et al., “Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk,” American Journal of Epidemiology, vol. 166, no. 6, pp. 697–708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. M. Morton, T. Zheng, T. R. Holford et al., “Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis,” Lancet Oncology, vol. 6, no. 7, pp. 469–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kricker, B. K. Armstrong, A. M. Hughes et al., “Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium,” International Journal of Cancer, vol. 122, no. 1, pp. 144–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Boffetta, O. van der Hel, A. Kricker et al., “Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma—a multicentre European case—control study,” International Journal of Epidemiology, vol. 37, no. 5, pp. 1080–1094, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Cocco, A. T'Mannetje, D. Fadda et al., “Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study,” Occupational and Environmental Medicine, vol. 67, no. 5, pp. 341–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Zhang, S. D. Sanjose, P. M. Bracci et al., “Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma,” American Journal of Epidemiology, vol. 167, no. 11, pp. 1321–1331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. de Sanjosé, Y. Benavente, A. Nieters et al., “Association between personal use of hair dyes and lymphoid neoplasms in Europe,” American Journal of Epidemiology, vol. 164, no. 1, pp. 47–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. E. V. Willett, L. M. Morton, P. Hartge et al., “Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph consortium,” International Journal of Cancer, vol. 122, no. 9, pp. 2062–2070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Ott and A. Rosenwald, “Molecular pathogenesis of follicular lymphoma,” Haematologica, vol. 93, no. 12, pp. 1773–1776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Schüler, C. Hirt, and G. Dölken, “Chromosomal translocation t(14;18) in healthy individuals,” Seminars in Cancer Biology, vol. 13, no. 3, pp. 203–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Kalra, S. P. Singh, S. M. Savage, G. L. Finch, and M. L. Sopori, “Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca2+ stores,” Journal of Pharmacology and Experimental Therapeutics, vol. 293, no. 1, pp. 166–171, 2000. View at Google Scholar · View at Scopus
  32. A. Monnereau, L. Orsi, X. Troussard et al., “Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study,” Cancer Causes and Control, vol. 19, no. 10, pp. 1147–1160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. B. C. H. Chiu, J. R. Cerhan, S. M. Gapstur et al., “Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women,” British Journal of Cancer, vol. 80, no. 9, pp. 1476–1482, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Kanda, K. Matsuo, M. Inoue et al., “Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based prospective study),” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 2, pp. 429–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. A. Holly, C. Lele, P. M. Bracci, and M. S. McGrath, “Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California,” American Journal of Epidemiology, vol. 150, no. 4, pp. 375–389, 1999. View at Google Scholar · View at Scopus
  36. E. De Stefani, L. Fierro, E. Barrios, and A. Ronco, “Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case-control study in Uruguay,” Leukemia Research, vol. 22, no. 5, pp. 445–452, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. D. S. Freedman, P. E. Tolbert, R. Coates, E. A. Brann, and C. R. Kjeldsberg, “Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men,” American Journal of Epidemiology, vol. 148, no. 9, pp. 833–841, 1998. View at Google Scholar · View at Scopus
  38. O. Wong, F. Harris, Y. Wang, and H. Fu, “A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of personal characteristics, lifestyle, and environmental risk factors by subtypes of the WHO classification,” Journal of Occupational and Environmental Medicine, vol. 52, no. 1, pp. 39–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Tavani, S. Gallus, C. La Vecchia, and S. Franceschi, “Alcohol drinking and risk of non-Hodgkin's lymphoma,” European Journal of Clinical Nutrition, vol. 55, no. 10, pp. 824–826, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. E. T. Chang, K. E. Smedby, S. M. Zhang et al., “Alcohol intake and risk of non-Hodgkin lymphoma in men and women,” Cancer Causes and Control, vol. 15, no. 10, pp. 1067–1076, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. B. C. H. Chiu, D. D. Weisenburger, K. P. Cantor et al., “Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men,” Annals of Epidemiology, vol. 12, no. 5, pp. 309–315, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. E. T. Chang, C. A. Clarke, A. J. Canchola et al., “Alcohol consumption over time and risk of lymphoid malignancies in the California Teachers Study cohort,” American Journal of Epidemiology, vol. 172, no. 12, pp. 1373–1383, 2010. View at Google Scholar · View at Scopus
  43. I. Tramacere, C. Pelucchi, M. Bonifazi et al., “Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis,” Annals of Oncology. In press.
  44. L. M. Morton, T. R. Holford, B. Leaderer et al., “Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States),” Cancer Causes and Control, vol. 14, no. 7, pp. 687–694, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. N. C. Briggs, R. S. Levine, L. D. Bobo, W. P. Haliburton, E. A. Brann, and C. H. Hennekens, “Wine drinking and risk of non-Hodgkin's lymphoma among men in the United States: a population-based case-control study,” American Journal of Epidemiology, vol. 156, no. 5, pp. 454–462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Jang, L. Cai, G. O. Udeani et al., “Cancer chemopreventive activity of resveratrol, a natural product derived from grapes,” Science, vol. 275, no. 5297, pp. 218–220, 1997. View at Google Scholar · View at Scopus
  47. P. Bruno, L. Ghisolfi, M. Priulla, A. Nicolin, and A. Bertelli, “Wine and tumors: study of resveratrol,” Drugs under Experimental and Clinical Research, vol. 29, no. 5-6, pp. 257–261, 2003. View at Google Scholar · View at Scopus
  48. L. E. Díaz, A. Montero, M. González-Gross, A. I. Vallejo, J. Romeo, and A. Marcos, “Influence of alcohol consumption on immunological status: a review,” European Journal of Clinical Nutrition, vol. 56, supplement 3, pp. S50–S53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Zhang, T. R. Holford, B. Leaderer et al., “Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut,” American Journal of Epidemiology, vol. 159, no. 2, pp. 148–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Benavente, N. Garcia, E. Domingo-Domenech et al., “Regular use of hair dyes and risk of lymphoma in Spain,” International Journal of Epidemiology, vol. 34, no. 5, pp. 1118–1122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Grodstein, C. H. Hennekens, G. A. Colditz, D. J. Hunter, and M. J. Stampfer, “A prospective study of permanent hair dye use and hematopoietic cancer,” Journal of the National Cancer Institute, vol. 86, no. 19, pp. 1466–1470, 1994. View at Google Scholar · View at Scopus
  52. J. B. Mendelsohn, Q. Z. Li, B. T. Ji et al., “Personal use of hair dye and cancer risk in a prospective cohort of Chinese women,” Cancer Science, vol. 100, no. 6, pp. 1088–1091, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. B. N. Ames, H. O. Kammen, and E. Yamasaki, “Hair dyes are mutagenic: identification of a variety of mutagenic ingredients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 6, pp. 2423–2427, 1975. View at Google Scholar · View at Scopus
  54. J. Adami, M. Frisch, J. Yuen, B. Glimelius, and M. Melbye, “Evidence of an association between non-Hodgkin's lymphoma and skin cancer,” British Medical Journal, vol. 310, no. 6993, pp. 1491–1495, 1995. View at Google Scholar · View at Scopus
  55. D. B. McKenna, D. Stockton, D. H. Brewster, and V. R. Doherty, “Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland,” British Journal of Cancer, vol. 88, no. 1, pp. 74–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. W. B. Goggins, D. M. Finkelstein, and H. Tsao, “Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma,” Cancer, vol. 91, pp. 874–880, 2001. View at Google Scholar
  57. P. Hall, I. Rosendahl, A. Mattsson, and S. Einhorn, “Non-Hodgkin's lymphoma and skin malignancies—shared etiology?” International Journal of Cancer, vol. 62, no. 5, pp. 519–522, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. K. K. Hanneman, K. D. Cooper, and E. D. Baron, “Ultraviolet immunosuppression: mechanisms and consequences,” Dermatologic Clinics, vol. 24, no. 1, pp. 19–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. M. S. Santos, S. N. Meydani, L. Leka et al., “Natural killer cell activity in elderly men is enhanced by β-carotene supplementation,” American Journal of Clinical Nutrition, vol. 64, no. 5, pp. 772–777, 1996. View at Google Scholar · View at Scopus
  60. H. K. Biesalski, C. Hemmes, W. Hopfenmuller, C. Schmid, and H. P. M. Gollnick, “Effects of controlled exposure of sunlight on plasma and skin levels of β-carotene,” Free Radical Research, vol. 24, no. 3, pp. 215–224, 1996. View at Google Scholar · View at Scopus
  61. G. Bentham, “Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales,” British Medical Journal, vol. 312, no. 7039, pp. 1128–1131, 1996. View at Google Scholar · View at Scopus
  62. A. J. McMichael and G. G. Giles, “Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?” British Journal of Cancer, vol. 73, no. 7, pp. 945–950, 1996. View at Google Scholar · View at Scopus
  63. S. Hu, F. Ma, F. Collado-Mesa, and R. S. Kirsner, “Ultraviolet Radiation and Incidence of non-Hodgkin's Lymphoma among Hispanics in the United States,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 1, pp. 59–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Hartge, S. S. Devesa, D. Grauman, T. R. Fears, and J. F. Fraumeni, “Non-Hodgkin's lymphoma and sunlight,” Journal of the National Cancer Institute, vol. 88, no. 5, pp. 298–300, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Zhang, T. R. Holford, B. Leaderer et al., “Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma,” American Journal of Epidemiology, vol. 165, no. 11, pp. 1255–1264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Adami, G. Gridley et al., “Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden,” International Journal of Cancer, vol. 80, pp. 641–645, 1999. View at Google Scholar
  67. K. A. Bertrand, E. T. Chang, G. A. Abel et al., “Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study,” Cancer Causes and Control, vol. 22, pp. 1731–1741, 2011. View at Google Scholar
  68. K. E. Smedby, H. Hjalgrim, M. Melbye et al., “Ultraviolet radiation exposure and risk of malignant lymphomas,” Journal of the National Cancer Institute, vol. 97, no. 3, pp. 199–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. L. K. Soni, L. Hou, S. M. Gapstur, A. M. Evens, D. D. Weisenburger, and B. C. H. Chiu, “Sun exposure and non-Hodgkin lymphoma: a population-based, case-control study,” European Journal of Cancer, vol. 43, no. 16, pp. 2388–2395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. A. M. Hughes, B. K. Armstrong, C. M. Vajdic et al., “Sun exposure may protect against non-Hodgkin lymphoma: a case-control study,” International Journal of Cancer, vol. 112, no. 5, pp. 865–871, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Weihkopf, N. Becker, A. Nieters et al., “Sun exposure and malignant lymphoma: a population-based case-control study in Germany,” International Journal of Cancer, vol. 120, no. 11, pp. 2445–2451, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. J. L. Kelly, J. W. Friedberg, L. M. Calvi, E. van Wijngaarden, and S. G. Fisher, “A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults,” Cancer Causes and Control, vol. 21, no. 8, pp. 1265–1275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. E. T. Petridou, S. K. Dikalioti, A. Skalkidou, E. Andrie, N. Dessypris, and D. Trichopoulos, “Sun exposure, birth weight, and childhood lymphomas: a case control study in Greece,” Cancer Causes and Control, vol. 18, no. 9, pp. 1031–1037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. E. T. Chang, A. J. Canchola, M. Cockburn et al., “Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study,” Blood, vol. 118, no. 6, pp. 1591–1599, 2011. View at Google Scholar
  75. B. K. Armstrong and A. Kricker, “Sun exposure and non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 396–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. M. P. Purdue, D. M. Freedman, S. M. Gapstur et al., “Circulating 25-Hydroxyvitamin D and risk of non-Hodgkin lymphoma: cohort Consortium Vitamin D Pooling Project of Rarer Cancers,” American Journal of Epidemiology, vol. 172, no. 1, pp. 58–69, 2010. View at Google Scholar · View at Scopus
  77. E. Erber, G. Maskarinec, U. Lim, and L. N. Kolonel, “Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort,” British Journal of Nutrition, vol. 103, no. 4, pp. 581–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. E. T. Chang, A. J. Canchola, M. Cockburn et al., “Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study,” Blood, vol. 118, pp. 1591–1599, 2011. View at Google Scholar
  79. S. E. Ullrich, “Does exposure to UV radiation induce a shift to a Th-2-like immune reaction?” Photochemistry and Photobiology, vol. 64, no. 2, pp. 254–258, 1996. View at Google Scholar · View at Scopus
  80. A. J. Sigurdson, M. M. Doody, R. S. Rao et al., “Cancer incidence in the U.S. Radiologic technologists health study, 1983-–1998,” Cancer, vol. 97, no. 12, pp. 3080–3089, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. M. S. Linet, D. M. Freedman, A. K. Mohan et al., “Incidence of haematopoietic malignancies in US radiologic technologists,” Occupational and Environmental Medicine, vol. 62, no. 12, pp. 861–867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. A. K. Mohan, M. Hauptmann, D. M. Freedman et al., “Cancer and other causes of mortality among radiologic technologists in the United States,” International Journal of Cancer, vol. 103, no. 2, pp. 259–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. J. D. Boice Jr., M. M. Morin, A. G. Glass et al., “Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma,” Journal of the American Medical Association, vol. 265, no. 10, pp. 1290–1294, 1991. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Pettersson, M. Ryberg, and B. Maler, “Second primary cancer after treatment of invasive corcinoma of the uterine cervix, compared with those arising after treatment for in situ carcinomas. An effect of irradiation? A cancer registry study,” Acta Obstetricia et Gynecologica Scandinavica, vol. 69, no. 2, pp. 161–174, 1990. View at Google Scholar · View at Scopus
  85. P. D. Inskip, R. A. Kleinerman, M. Stovall et al., “Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease,” Radiation Research, vol. 135, no. 1, pp. 108–124, 1993. View at Google Scholar · View at Scopus
  86. S. C. Darby, G. Reeves, T. Key, R. Doll, and M. Stovall, “Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica,” International Journal of Cancer, vol. 56, no. 6, pp. 793–801, 1994. View at Google Scholar · View at Scopus
  87. K. K. Karipidis, G. Benke, M. R. Sim et al., “Non-Hodgkin lymphoma and occupational radiation exposure assessed using local data,” Occupational Medicine, vol. 59, no. 6, pp. 437–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. K. K. Karipidis, G. Benke, M. R. Sim et al., “Occupational exposure to ionizing and non-ionizing radiation and risk of non-Hodgkin lymphoma,” International Archives of Occupational and Environmental Health, vol. 80, no. 8, pp. 663–670, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. C. R. Eheman, P. E. Tolbert, R. J. Coates, O. Devine, and J. W. Eley, “Case-control assessment of the association between non-Hodgkin's lymphoma and occupational radiation with doses assessed using a job exposure matrix,” American Journal of Industrial Medicine, vol. 38, pp. 19–27, 2000. View at Google Scholar
  90. D. B. Richardson, C. Terschüren, and W. Hoffmann, “Occupational risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Northern Germany,” American Journal of Industrial Medicine, vol. 51, no. 4, pp. 258–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Shimizu, H. Kato, and W. J. Schull, “Studies of the mortality of A-bomb survivors: 9. Mortality, 1950–1985: part 2. Cancer mortality based on the recently revised doses (DS86),” Radiation Research, vol. 121, no. 2, pp. 120–141, 1990. View at Google Scholar · View at Scopus
  92. Y. Shimizu, W. J. Schull, and H. Kato, “Cancer risk among atomic bomb survivors. The RERF life span study,” Journal of the American Medical Association, vol. 264, no. 5, pp. 601–604, 1990. View at Publisher · View at Google Scholar · View at Scopus
  93. D. B. Richardson, H. Sugiyama, S. Wing et al., “Positive associations between ionizing radiation and lymphoma mortality among men,” American Journal of Epidemiology, vol. 169, no. 8, pp. 969–976, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Berrington, S. C. Darby, H. A. Weiss, and R. Doll, “100 years of observation on British radiologists: mortality from cancer and other causes 1897–1997,” British Journal of Radiology, vol. 74, no. 882, pp. 507–519, 2001. View at Google Scholar · View at Scopus
  95. H. A. Weiss, S. C. Darby, and R. Doll, “Cancer mortality following x-ray treatment for ankylosing spondylitis,” International Journal of Cancer, vol. 59, no. 3, pp. 327–338, 1994. View at Publisher · View at Google Scholar · View at Scopus
  96. B. Krishnan and G. J. Morgan, “Non-Hodgkin lymphoma secondary to cancer chemotherapy,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 377–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. C. F. Skibola, “Obesity, diet and risk of non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 392–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. M. P. Purdue, D. G. Bassani, N. S. Klar et al., “Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case-control analysis,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 10, pp. 1665–1676, 2004. View at Google Scholar · View at Scopus
  99. B. C. H. Chiu, J. R. Cerhan, A. R. Folsom et al., “Diet and risk of non-Hodgkin lymphoma in older women,” Journal of the American Medical Association, vol. 275, no. 17, pp. 1315–1321, 1996. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Zhang, D. J. Hunter, B. A. Rosner et al., “Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women,” Journal of the National Cancer Institute, vol. 91, no. 20, pp. 1751–1758, 1999. View at Google Scholar · View at Scopus
  101. T. Zheng, T. R. Holford, B. Leaderer et al., “Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in connecticut women,” American Journal of Epidemiology, vol. 159, no. 5, pp. 454–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. A. J. Cross, M. H. Ward, M. J. Schenk et al., “Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study,” Carcinogenesis, vol. 27, no. 2, pp. 293–297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. D. A. Hughes, “Effects of dietary antioxidants on the immune function of middle-aged adults,” Proceedings of the Nutrition Society, vol. 58, no. 1, pp. 79–84, 1999. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Selhub, “Homocysteine metabolism,” Annual Review of Nutrition, vol. 19, pp. 217–246, 1999. View at Google Scholar
  105. J. Polesel, R. Talamini, M. Montella et al., “Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study,” Annals of Oncology, vol. 17, no. 4, pp. 713–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. S. M. Zhang, D. J. Hunter, B. A. Rosner et al., “Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women,” Cancer Epidemiology Biomarkers and Prevention, vol. 9, no. 5, pp. 477–485, 2000. View at Google Scholar · View at Scopus
  107. L. E. Kelemen, J. R. Cerhan, U. Lim et al., “Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study,” American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1401–1410, 2006. View at Google Scholar · View at Scopus
  108. E. T. Chang, K. M. Bälter, A. Torrång et al., “Nutrient intake and risk of non-Hodgkin's lymphoma,” American Journal of Epidemiology, vol. 164, no. 12, pp. 1222–1232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. C. A. Thompson, T. M. Habermann, A. H. Wang et al., “Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study,” International Journal of Cancer, vol. 126, no. 4, pp. 992–1003, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. U. Lim, S. Weinstein, D. Albanes et al., “Dietary factors of one-carbon metabolism in relation to non-Hodgkin lymphoma and multiple myeloma in a cohort of male smokers,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 6, pp. 1109–1114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. U. Lim, M. Schenk, L. E. Kelemen et al., “Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998–2000,” American Journal of Epidemiology, vol. 162, no. 10, pp. 953–964, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Koutros, Y. Zhang, Y. Zhu et al., “Nutrients contributing to one-carbon metabolism and risk of non-Hodgkin lymphoma subtypes,” American Journal of Epidemiology, vol. 167, pp. 287–294, 2008. View at Google Scholar
  113. J. Polesel, L. Dal Maso, C. La Vecchia et al., “Dietary folate, alcohol consumption, and risk of non-Hodgkin lymphoma,” Nutrition and Cancer, vol. 57, no. 2, pp. 146–150, 2007. View at Google Scholar · View at Scopus
  114. U. Lim, S. S. Wang, P. Hartge et al., “Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study,” Blood, vol. 109, no. 7, pp. 3050–3059, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Steinkellner, S. Rabot, C. Freywald et al., “Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 480-481, pp. 285–297, 2001. View at Google Scholar · View at Scopus
  116. P. Boffetta and F. de Vocht, “Occupation and the risk of non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 369–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  117. A. 'T Mannetje, E. Dryson, C. Walls et al., “High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study,” Occupational and Environmental Medicine, vol. 65, no. 5, pp. 354–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. T. Zheng, A. Blair, Y. Zhang, D. D. Weisenburger, and S. H. Zahm, “Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia,” Journal of Occupational and Environmental Medicine, vol. 44, no. 5, pp. 469–474, 2002. View at Google Scholar · View at Scopus
  119. L. Fritschi, K. C. Johnson, E. V. Kliewer, and R. Fry, “Animal-related occupations and the risk of leukemia, myeloma, and non-Hodgkin's lymphoma in Canada,” Cancer Causes and Control, vol. 13, no. 6, pp. 563–571, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. C. P. Karunanayake, H. H. McDuffie, J. A. Dosman, J. J. Spinelli, and P. Pahwa, “Occupational exposures and non-Hodgkin's lymphoma: canadian case-control study,” Environmental Health, vol. 7, article 44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Orsi, X. Troussard, A. Monnereau et al., “Occupation and lymphoid malignancies: results from a French case-control study,” Journal of Occupational and Environmental Medicine, vol. 49, no. 12, pp. 1339–1350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. J. Acquavella, G. Olsen, P. Cole et al., “Cancer among farmers: a meta-analysis,” Annals of Epidemiology, vol. 8, no. 1, pp. 64–74, 1998. View at Publisher · View at Google Scholar · View at Scopus
  123. S. A. Khuder, E. A. Schaub, and J. E. Keller-Byrne, “Meta-analyses of non-Hodgkin's lymphoma and farming,” Scandinavian Journal of Work, Environment and Health, vol. 24, no. 4, pp. 255–261, 1998. View at Google Scholar · View at Scopus
  124. J. E. Keller-Byrne, S. A. Khuder, E. A. Schaub, and O. McAfee, “A meta-analysis of non-Hodgkin's lymphoma among farmers in the central United States,” American Journal of Industrial Medicine, vol. 31, pp. 442–444, 1997. View at Google Scholar
  125. M. A. Svec, M. H. Ward, M. Dosemeci, H. Checkoway, and A. J. De Roos, “Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public,” Occupational and Environmental Medicine, vol. 62, no. 10, pp. 726–735, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. D. Amadori, O. Nanni, F. Falcini et al., “Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on job titles,” Occupational and Environmental Medicine, vol. 52, no. 6, pp. 374–379, 1995. View at Google Scholar · View at Scopus
  127. L. Miligi, A. Seniori Costantini, P. Crosignani et al., “Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women,” American Journal of Industrial Medicine, vol. 36, pp. 60–69, 1999. View at Google Scholar
  128. B. Mester, A. Nieters, E. Deeg, G. Elsner, N. Becker, and A. Seidler, “Occupation and malignant lymphoma: a population based case control study in Germany,” Occupational and Environmental Medicine, vol. 63, no. 1, pp. 17–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. P. R. Band, N. D. Le, R. Fang, and R. Gallagher, “Identification of occupational cancer risks in British Columbia: a population-based case-control study of 769 cases of non-Hodgkin's lymphoma analyzed by histopathology subtypes,” Journal of Occupational and Environmental Medicine, vol. 46, no. 5, pp. 479–489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. D. Neasham, A. Sifi, and K. R. Nielsen, “Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC),” Occupational and Environmental Medicine, vol. 68, no. 1, pp. 77–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. L. Tatham, P. Tolbert, and C. Kjeldsberg, “Occupational risk factors for subgroups of non-Hodgkin's lymphoma,” Epidemiology, vol. 8, no. 5, pp. 551–558, 1997. View at Publisher · View at Google Scholar · View at Scopus
  132. T. Moore, P. Brennan, N. Becker et al., “Occupational exposure to meat and risk of lymphoma: a multicenter case-control study from Europe,” International Journal of Cancer, vol. 121, no. 12, pp. 2761–2766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  133. M. I. Cano and M. Pollán, “Non-Hodgkin's lymphomas and occupation in Sweden,” International Archives of Occupational and Environmental Health, vol. 74, no. 6, pp. 443–449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  134. J. Ji and K. Hemminki, “Socioeconomic/occupational risk factors for lymphoproliferative diseases in Sweden,” Annals of Epidemiology, vol. 16, no. 5, pp. 370–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Schenk, M. P. Purdue, J. S. Colt et al., “Occupation/industry and risk of non-Hodgkin's lymphoma in the United States,” Occupational and Environmental Medicine, vol. 66, pp. 23–31, 2009. View at Google Scholar
  136. A. S. Costantini, L. Miligi, D. Kriebel et al., “A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation,” Epidemiology, vol. 12, no. 1, pp. 78–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Orsi, A. Monnereau, B. Dananche et al., “Occupational exposure to organic solvents and lymphoid neoplasms in men: results of a French case-control study,” Occupational and Environmental Medicine, vol. 67, no. 10, pp. 664–672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. L. Fritschi, G. Benke, A. M. Hughes et al., “Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia),” Cancer Causes and Control, vol. 16, no. 5, pp. 599–607, 2005. View at Publisher · View at Google Scholar · View at Scopus
  139. M. A. V. Rêgo, C. S. Campos Sousa, M. Kato, A. Barreto de Carvalho, D. Loomis, and F. M. Carvalho, “Non-Hodgkin's lymphomas and organic solvents,” Journal of Occupational and Environmental Medicine, vol. 44, no. 9, pp. 874–881, 2002. View at Google Scholar · View at Scopus
  140. I. Kato, K. L. Koenig, H. Watanabe-Meserve et al., “Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States),” Cancer Causes and Control, vol. 16, no. 10, pp. 1215–1224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. E. Dryver, L. Brandt, T. Kauppinen, and H. Olsson, “Occupational exposures and non-Hodgkin's lymphoma in Southern Sweden,” International Journal of Occupational and Environmental Health, vol. 10, no. 1, pp. 13–21, 2004. View at Google Scholar · View at Scopus
  142. P. Vineis, L. Miligi, and A. S. Costantini, “Exposure to solvents and risk of non-Hodgkin lymphoma: clues on putative mechanisms,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 381–384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. R. Wang, Y. Zhang, Q. Lan et al., “Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women,” American Journal of Epidemiology, vol. 169, no. 2, pp. 176–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. L. Miligi, A. S. Costantini, A. Benvenuti et al., “Occupational exposure to solvents and the risk of lymphomas,” Epidemiology, vol. 17, no. 5, pp. 552–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  145. N. C. Briggs, R. S. Levine, H. I. Hall, O. Cosby, E. A. Brann, and C. H. Hennekens, “Occupational risk factors for selected cancers among African American and white men in the United States,” American Journal of Public Health, vol. 93, no. 10, pp. 1748–1752, 2003. View at Google Scholar · View at Scopus
  146. R. B. Hayes, S. N. Yin, M. Dosemeci et al., “Benzene and the dose-related incidence of hematologic neoplasms in China,” Journal of the National Cancer Institute, vol. 89, no. 14, pp. 1065–1071, 1997. View at Google Scholar · View at Scopus
  147. E. V. Kane and R. Newton, “Benzene and the risk of non-Hodgkin lymphoma: a review and meta-analysis of the literature,” Cancer Epidemiology, vol. 34, no. 1, pp. 7–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. M. T. Smith, R. M. Jones, and A. H. Smith, “Benzene exposure and risk of non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 385–391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. D. D. Alexander and M. E. Wagner, “Benzene exposure and non-Hodgkin lymphoma: a meta-analysis of epidemiologic studies,” Journal of Occupational and Environmental Medicine, vol. 52, no. 2, pp. 169–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. R. A. Rinsky, R. W. Hornung, S. R. Silver, and C. Y. Tseng, “Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment,” American Journal of Industrial Medicine, vol. 42, no. 6, pp. 474–480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Steinmaus, A. H. Smith, R. M. Jones, and M. T. Smith, “Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association,” Occupational and Environmental Medicine, vol. 65, no. 6, pp. 371–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. J. Vlaanderen, Q. Lan, H. Kromhout, N. Rothman, and R. Vermeulen, “Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions,” Environmental Health Perspectives, vol. 119, no. 2, pp. 159–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. C. S. Scott and W. A. Chiu, “Trichloroethylene cancer epidemiology: a consideration of select issues,” Environmental Health Perspectives, vol. 114, no. 9, pp. 1471–1478, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. O. Raaschou-Nielsen, J. Hansen, J. K. McLaughlin et al., “Cancer risk among workers at danish companies using trichloroethylene: a Cohort Study,” American Journal of Epidemiology, vol. 158, no. 12, pp. 1182–1192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  155. J. Hansen, O. Raaschou-Nielsen, J. M. Christensen et al., “Cancer incidence among danish workers exposed to trichloroethylene,” Journal of Occupational and Environmental Medicine, vol. 43, no. 2, pp. 133–139, 2001. View at Google Scholar · View at Scopus
  156. A. Blair, P. Hartge, P. A. Stewart, M. McAdams, and J. Lubin, “Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: extended follow up,” Occupational and Environmental Medicine, vol. 55, no. 3, pp. 161–171, 1998. View at Google Scholar · View at Scopus
  157. A. Anttila, E. Pukkala, M. Sallmen, S. Hernberg, and K. Hemminki, “Cancer incidence among Finnish workers exposed to halogenated hydrocarbons,” Journal of Occupational and Environmental Medicine, vol. 37, no. 7, pp. 797–806, 1995. View at Publisher · View at Google Scholar · View at Scopus
  158. O. Axelson, A. Selden, K. Andersson, and C. Hogstedt, “Updated and expanded Swedish cohort study on trichloroethylene and cancer risk,” Journal of Occupational Medicine, vol. 36, no. 5, pp. 556–562, 1994. View at Google Scholar · View at Scopus
  159. J. H. Mandel, M. A. Kelsh, P. J. Mink et al., “Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: a meta-analysis and review,” Occupational and Environmental Medicine, vol. 63, no. 9, pp. 597–607, 2006. View at Publisher · View at Google Scholar · View at Scopus
  160. D. Wartenberg, D. Reyner, and C. S. Scott, “Trichloroethylene and cancer: epidemiologic evidence,” Environmental Health Perspectives, vol. 108, supplement 2, pp. 161–176, 2000. View at Google Scholar · View at Scopus
  161. M. P. Purdue, B. Bakke, P. Stewart et al., “A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma,” Environmental Health Perspectives, vol. 119, no. 2, pp. 232–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  162. Q. Lan, L. Zhang, X. Tang et al., “Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers,” Carcinogenesis, vol. 31, no. 9, pp. 1592–1596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. Q. Lan, L. Zhang, G. Li et al., “Hematotoxicity in workers exposed to low levels of benzene,” Science, vol. 306, no. 5702, pp. 1774–1776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  164. G. S. Cooper, S. L. Makris, P. J. Nietert, and J. Jinot, “Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans,” Environmental Health Perspectives, vol. 117, no. 5, pp. 696–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. S. Ennaceur, D. Ridha, and R. Marcos, “Genotoxicity of the organochlorine pesticides 1,1-dichloro-2,2- bis(p-chlorophenyl)ethylene (DDE) and hexachlorobenzene (HCB) in cultured human lymphocytes,” Chemosphere, vol. 71, no. 7, pp. 1335–1339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. S. P. Bhunya and G. B. Jena, “Genotoxic potential of the organochlorine insecticide lindane (gamma-BHC): an in vivo study in chicks,” Mutation Research, vol. 272, no. 2, pp. 175–181, 1992. View at Google Scholar · View at Scopus
  167. K. P. Cantor, A. Blair, G. Everett et al., “Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota,” Cancer Research, vol. 52, no. 9, pp. 2447–2455, 1992. View at Google Scholar · View at Scopus
  168. H. H. McDuffie, P. Pahwa, J. R. McLaughlin et al., “Non-Hodgkin's lymphoma and specific pesticide exposures inmen: cross-Canada study of pesticides and health,” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 11, pp. 1155–1163, 2001. View at Google Scholar · View at Scopus
  169. J. F. Viel, N. Floret, E. Deconinck, J. F. Focant, E. De Pauw, and J. Y. Cahn, “Increased risk of non-Hodgkin lymphoma and serum organochlorine concentrations among neighbors of a municipal solid waste incinerator,” Environment International, vol. 37, no. 2, pp. 449–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  170. P. J. E. Quintana, R. J. Delfino, S. Korrick et al., “Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma,” Environmental Health Perspectives, vol. 112, no. 8, pp. 854–861, 2004. View at Google Scholar · View at Scopus
  171. J. J. Spinelli, C. H. Ng, J. P. Weber et al., “Organochlorines and risk of non-Hodgkin lymphoma,” International Journal of Cancer, vol. 121, no. 12, pp. 2767–2775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  172. P. Cocco, P. Brennan, A. Ibba et al., “Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes,” Occupational and Environmental Medicine, vol. 65, no. 2, pp. 132–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. K. P. Cantor, P. T. Strickland, J. W. Brock et al., “Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: β-Hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene,” Environmental Health Perspectives, vol. 111, no. 2, pp. 179–183, 2003. View at Google Scholar · View at Scopus
  174. F. Laden, K. A. Bertrand, L. Altshul, J. C. Aster, S. A. Korrick, and S. K. Sagiv, “Plasma organochlorine levels and risk of non-Hodgkin lymphoma in the nurses' health study,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 5, pp. 1381–1384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. D. Baris, S. H. Zahm, K. P. Cantor, and A. Blair, “Agricultural use of DDT and risk of non-Hodgkin's lymphoma: pooled analysis of three case-control studies in the United States,” Occupational and Environmental Medicine, vol. 55, no. 8, pp. 522–527, 1998. View at Google Scholar · View at Scopus
  176. L. S. Engel, F. Laden, A. Andersen et al., “Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts,” Cancer Research, vol. 67, no. 11, pp. 5545–5552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  177. E. V. Brauner, M. Sorensen, E. Gaudreau et al., “A prospective study of organochlorines in adipose tissue and risk of nonHodgkin lymphoma,” Environmental Health Perspectives, vol. 120, pp. 105–111, 2012. View at Google Scholar
  178. A. J. De Roos, S. H. Zahm, K. P. Cantor et al., “Integrative assessment of multiple pesticides as risk factors for non-Hodgkin's lymphoma among men,” Occupational and Environmental Medicine, vol. 60, no. 9, p. E11, 2003. View at Google Scholar · View at Scopus
  179. A. D. Lieberman, M. R. Craven, H. A. Lewis, and J. H. Nemenzo, “Genotoxicity from domestic use of organophosphate pesticides,” Journal of Occupational and Environmental Medicine, vol. 40, no. 11, pp. 954–957, 1998. View at Google Scholar · View at Scopus
  180. C. Bolognesi, M. Peluso, P. Degan, R. Rabboni, A. Munnia, and A. Abbondandolo, “Genotoxic effects of the carbamate insecticide, methomyl. II. In vivo studies with pure compound and the technical formulation, “Lannate 25”,” Environmental and Molecular Mutagenesis, vol. 24, no. 3, pp. 235–242, 1994. View at Publisher · View at Google Scholar · View at Scopus
  181. B. L. Waddell, S. H. Zahm, D. Baris et al., “Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States),” Cancer Causes and Control, vol. 12, no. 6, pp. 509–517, 2001. View at Publisher · View at Google Scholar · View at Scopus
  182. T. Zheng, S. H. Zahm, K. P. Cantor, D. D. Weisenburger, Y. Zhang, and A. Blair, “Agricultural exposure to carbamate pesticides and risk of non-Hodgkin lymphoma,” Journal of Occupational and Environmental Medicine, vol. 43, no. 7, pp. 641–649, 2001. View at Google Scholar · View at Scopus
  183. L. Miligi, A. S. Costantini, V. Bolejack et al., “Non-Hodgkin's lymphoma, leukemia, and exposures in agriculture: results from the Italian Multicenter Case-Control Study,” American Journal of Industrial Medicine, vol. 44, no. 6, pp. 627–636, 2003. View at Publisher · View at Google Scholar · View at Scopus
  184. R. Mahajan, A. Blair, J. Coble et al., “Carbaryl exposure and incident cancer in the Agricultural Health Study,” International Journal of Cancer, vol. 121, no. 8, pp. 1799–1805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  185. B. P. Singh, L. Smghal, and R. S. Chauhan, “Immunotoxicity of carbaryl in chicken,” Indian Journal of Experimental Biology, vol. 45, no. 10, pp. 890–895, 2007. View at Google Scholar · View at Scopus
  186. L. Hardell, M. Eriksson, and M. Nordström, “Exposure to pesticides as risk factor for Non-Hodgkin's lymphoma and hairy cell leukemia: pooled analysis of two Swedish case-control studies,” Leukemia and Lymphoma, vol. 43, no. 5, pp. 1043–1049, 2002. View at Google Scholar · View at Scopus
  187. M. Eriksson, L. Hardell, M. Carlberg, and M. Åkerman, “Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis,” International Journal of Cancer, vol. 123, no. 7, pp. 1657–1663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  188. L. Hardell and M. Eriksson, “A case-control study of non-Hodgkin lymphoma and exposure to pesticides,” Cancer, vol. 85, pp. 1353–1360, 1999. View at Google Scholar
  189. J. A. Rusiecki, A. De Roos, W. J. Lee et al., “Cancer incidence among pesticide applicators exposed to Atrazine in the agricultural health study,” Journal of the National Cancer Institute, vol. 96, no. 18, pp. 1375–1382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  190. L. E. Freeman, J. A. Rusiecki, J. A. Hoppin et al., “Atrazine and cancer incidence among pesticide applicators in the agricultural health study (1994–2007),” Environmental Health Perspectives, vol. 119, pp. 1253–1259, 2011. View at Google Scholar
  191. L. S. Engel, Q. Lan, and N. Rothman, “Polychlorinated biphenyls and non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 373–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  192. N. Rothman, K. P. Cantor, A. Blair et al., “A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues,” The Lancet, vol. 350, no. 9073, pp. 240–244, 1997. View at Publisher · View at Google Scholar · View at Scopus
  193. A. J. De Roos, P. Hartge, J. H. Lubin et al., “Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma,” Cancer Research, vol. 65, no. 23, pp. 11214–11226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  194. M. S. Wolff, D. Camann, M. Gammon, and S. D. Stellman, “Proposed PCB congener groupings for epidemiological studies,” Environmental Health Perspectives, vol. 105, no. 1, pp. 13–14, 1997. View at Google Scholar · View at Scopus
  195. S. Villeneuve, L. Orsi, A. Monnereau et al., “Increased frequency of hematopoietic malignancies In relatives of patients with lymphoid neoplasms: a French case-control study,” International Journal of Cancer, vol. 124, no. 5, pp. 1188–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  196. F. K. Mensah, E. V. Willett, P. Ansell, P. J. Adamson, and E. Roman, “Non-Hodgkin's lymphoma and family history of hematologic malignancy,” American Journal of Epidemiology, vol. 165, no. 2, pp. 126–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  197. S. S. Wang, S. L. Slager, P. Brennan et al., “Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph),” Blood, vol. 109, no. 8, pp. 3479–3488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  198. E. A. Engels, “Infectious agents as causes of non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 3, pp. 401–404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  199. L. Dal Maso and S. Franceschi, “Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS,” Lancet Oncology, vol. 4, no. 2, pp. 110–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
  200. N. Crum-Cianflone, K. H. Hullsiek, V. Marconi et al., “Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study,” Acquired Immune Deficiency Syndrome, vol. 23, no. 1, pp. 41–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  201. G. Gaidano, D. Capello, and A. Carbone, “The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis,” Seminars in Oncology, vol. 27, no. 4, pp. 431–441, 2000. View at Google Scholar · View at Scopus
  202. A. Carbone and A. Gloghini, “AIDS-related lymphomas: from pathogenesis to pathology,” British Journal of Haematology, vol. 130, no. 5, pp. 662–670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  203. E. C. Breen, S. K. Hussain, L. Magpantay et al., “B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 7, pp. 1303–1314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  204. E. A. Engels, R. M. Pfeiffer, O. Landgren, and R. D. Moore, “Immunologic and virologic predictors of AIDS-related non-Hodgkin lymphoma in the highly active antiretroviral therapy Era,” Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 1, pp. 78–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  205. L. S. Young and A. B. Rickinson, “Epstein-Barr virus: 40 years on,” Nature Reviews Cancer, vol. 4, no. 10, pp. 757–768, 2004. View at Publisher · View at Google Scholar · View at Scopus
  206. H. Hjalgrim and E. A. Engels, “Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence,” Journal of Internal Medicine, vol. 264, no. 6, pp. 537–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  207. H. E. Heslop, “Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas,” Hematology, pp. 260–266, 2005. View at Google Scholar · View at Scopus
  208. N. Becker, M. O. Falster, C. M. Vajdic et al., “Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis,” International Journal of Cancer. In press.
  209. N. Becker, J. Fortuny, T. Alvaro et al., “Medical history and risk of lymphoma: results of a European case-control study (EPILYMPH),” Journal of Cancer Research and Clinical Oncology, vol. 135, no. 8, pp. 1099–1107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  210. K. Arisawa, M. Soda, S. Endo et al., “Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan,” International Journal of Cancer, vol. 85, pp. 319–324, 2000. View at Google Scholar
  211. K. E. Foreman, P. E. Bacon, E. D. Hsi, and B. J. Nickoloff, “In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma,” Journal of Clinical Investigation, vol. 99, no. 12, pp. 2971–2978, 1997. View at Google Scholar · View at Scopus
  212. L. Wang, N. Wakisaka, C. C. Tomlinson et al., “The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors,” Cancer Research, vol. 64, no. 10, pp. 2774–2781, 2004. View at Publisher · View at Google Scholar · View at Scopus
  213. F. Marcucci and A. Mele, “Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities,” Blood, vol. 117, no. 6, pp. 1792–1798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  214. A. Mele, A. Pulsoni, E. Bianco et al., “Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study,” Blood, vol. 102, no. 3, pp. 996–999, 2003. View at Publisher · View at Google Scholar · View at Scopus
  215. A. S. Duberg, M. Nordström, A. Törner et al., “Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection,” Hepatology, vol. 41, no. 3, pp. 652–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  216. L. A. Anderson and E. A. Engels, “Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship?” International Journal of Cancer, vol. 122, no. 8, pp. 10–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  217. C. S. Rabkin, B. H. Tess, R. E. Christianson et al., “Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia,” Blood, vol. 99, no. 11, pp. 4240–4242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  218. L. A. Anderson, R. Pfeiffer, J. L. Warren et al., “Hematopoietic malignancies associated with viral and alcoholic hepatitis,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 11, pp. 3069–3075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  219. L. Dal Maso and S. Franceschi, “Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 11, pp. 2078–2085, 2006. View at Publisher · View at Google Scholar · View at Scopus
  220. S. de Sanjose, Y. Benavente, C. M. Vajdic et al., “Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the international lymphoma epidemiology consortium,” Clinical Gastroenterology and Hepatology, vol. 6, no. 4, pp. 451–458, 2008. View at Publisher · View at Google Scholar · View at Scopus
  221. J. P. Gisbert, L. García-Buey, J. M. Pajares, and R. Moreno-Otero, “Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 6, pp. 653–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  222. J. G. Kusters, A. H. M. van Vliet, and E. J. Kuipers, “Pathogenesis of Helicobacter pylori infection,” Clinical Microbiology Reviews, vol. 19, no. 3, pp. 449–490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  223. J. Parsonnet, S. Hansen, L. Rodriguez et al., “Helicobacter pylori infection and gastric lymphoma,” The New England Journal of Medicine, vol. 330, no. 18, pp. 1267–1271, 1994. View at Publisher · View at Google Scholar · View at Scopus
  224. X. Sagaert, E. Van Cutsem, G. De Hertogh, K. Geboes, and T. Tousseyn, “Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development,” Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 6, pp. 336–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  225. S. Luminari, M. Cesaretti, L. Marcheselli et al., “Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas,” Annals of Oncology, vol. 21, no. 4, pp. 855–859, 2009. View at Publisher · View at Google Scholar · View at Scopus
  226. M. Q. Du, “MALT lymphoma : recent advances in aetiology and molecular genetics,” Journal of Clinical and Experimental Hematopathology, vol. 47, no. 2, pp. 31–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  227. A. Martí, A. Marcos, and J. A. Martínez, “Obesity and immune function relationships,” Obesity Reviews, vol. 2, no. 2, pp. 131–140, 2001. View at Google Scholar · View at Scopus
  228. S. C. Larsson and A. Wolk, “Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis,” International Journal of Cancer, vol. 121, no. 7, pp. 1564–1570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  229. S. C. Larsson and A. Wolk, “Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies,” European Journal of Cancer, vol. 47, no. 16, pp. 2422–2430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  230. G. Maskarinec, E. Erber, J. Gill, W. Cozen, and L. N. Kolonel, “Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 1, pp. 196–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  231. R. D. Pylypchuk, L. J. Schouten, R. A. Goldbohm, H. C. Schouten, and P. A. van den Brandt, “Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study,” vol. 170, no. 3, pp. 297–307, 2009. View at Google Scholar
  232. L. A. Anderson, S. Gadalla, L. M. Morton et al., “Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies,” International Journal of Cancer, vol. 125, no. 2, pp. 398–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  233. K. E. Smedby, C. M. Vajdic, M. Falster et al., “Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium,” Blood, vol. 111, no. 8, pp. 4029–4038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  234. K. E. Smedby, H. Hjalgrim, J. Askling et al., “Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype,” Journal of the National Cancer Institute, vol. 98, no. 1, pp. 51–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  235. E. A. Engels, J. R. Cerhan, M. S. Linet et al., “Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study,” American Journal of Epidemiology, vol. 162, no. 12, pp. 1153–1161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  236. E. Zintzaras, M. Voulgarelis, and H. M. Moutsopoulos, “The risk of lymphoma development in autoimmune diseases: a meta-analysis,” Archives of Internal Medicine, vol. 165, no. 20, pp. 2337–2344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  237. K. C. Söderberg, F. Jonsson, O. Winqvist, L. Hagmar, and M. Feychting, “Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden,” European Journal of Cancer, vol. 42, no. 17, pp. 3028–3033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  238. E. Theander, G. Henriksson, O. Ljungberg, T. Mandl, R. Manthorpe, and L. T. H. Jacobsson, “Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors,” Annals of the Rheumatic Diseases, vol. 65, no. 6, pp. 796–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  239. M. Kauppi, E. Pukkala, and H. Isomäki, “Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland),” Cancer Causes and Control, vol. 8, no. 2, pp. 201–204, 1997. View at Publisher · View at Google Scholar · View at Scopus
  240. M. Pertovaara, E. Pukkala, P. Laippala, A. Miettinen, and A. Pasternack, “A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects,” Annals of the Rheumatic Diseases, vol. 60, no. 5, pp. 467–472, 2001. View at Publisher · View at Google Scholar · View at Scopus
  241. S. Bernatsky, J. F. Boivin, L. Joseph et al., “An international cohort study of cancer in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 52, no. 5, pp. 1481–1490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  242. L. Björnådal, B. Löfström, L. Yin, I. E. Lundberg, and A. Ekbom, “Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus,” Scandinavian Journal of Rheumatology, vol. 31, no. 2, pp. 66–71, 2002. View at Publisher · View at Google Scholar · View at Scopus
  243. M. L. Mearin, C. Catassi, N. Brousse et al., “European multi-centre study on coeliac disease and non-Hodgkin lymphoma,” European Journal of Gastroenterology and Hepatology, vol. 18, no. 2, pp. 187–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  244. C. Catassi, E. Fabiani, G. Corrao et al., “Risk of non-Hodgkin lymphoma in celiac disease,” Journal of the American Medical Association, vol. 287, no. 11, pp. 1413–1419, 2002. View at Google Scholar · View at Scopus
  245. J. Askling, M. Linet, G. Gridley, T. S. Halstensen, K. Ekström, and A. Ekbom, “Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis,” Gastroenterology, vol. 123, no. 5, pp. 1428–1435, 2002. View at Google Scholar · View at Scopus
  246. E. Thomas, D. H. Brewster, R. J. Black, and G. J. Macfarlane, “Risk of malignancy among patients with rheumatic conditions,” International Journal of Cancer, vol. 88, pp. 497–502, 2000. View at Google Scholar
  247. K. Ekström, H. Hjalgrim, L. Brandt et al., “Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives,” Arthritis and Rheumatism, vol. 48, no. 4, pp. 963–970, 2003. View at Publisher · View at Google Scholar · View at Scopus
  248. K. E. Smedby, E. Baecklund, and J. Askling, “Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 11, pp. 2069–2077, 2006. View at Publisher · View at Google Scholar · View at Scopus
  249. J. Delabie, H. Holte, J. M. Vose et al., “Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-Cell lymphoma project,” Blood, vol. 118, no. 1, pp. 148–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  250. M. Troch, S. Woehrer, B. Streubel et al., “Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma,” Annals of Oncology, vol. 19, no. 7, pp. 1336–1339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  251. C. M. Vajdic, M. O. Falster, S. de Sanjose et al., “Atopic disease and risk of non-Hodgkin lymphoma: an interlymph pooled analysis,” Cancer Research, vol. 69, no. 16, pp. 6482–6489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  252. A. E. Grulich, C. M. Vajdic, J. M. Kaldor et al., “Birth order, atopy, and risk of non-Hodgkin lymphoma,” Journal of the National Cancer Institute, vol. 97, no. 8, pp. 587–594, 2005. View at Publisher · View at Google Scholar · View at Scopus
  253. W. Cozen, J. R. Cerhan, O. Martinez-Maza et al., “The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk,” Cancer Causes and Control, vol. 18, no. 8, pp. 821–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  254. N. Becker, S. de Sanjose, A. Nieters et al., “Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph,” Leukemia Research, vol. 31, no. 10, pp. 1365–1372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  255. P. Vineis, R. Tumino, C. Vigano et al., “Delayed infection, family size and malignant lymphomas,” Journal of Epidemiology and Community Health, vol. 54, no. 12, pp. 907–911, 2000. View at Publisher · View at Google Scholar · View at Scopus
  256. P. M. Bracci, T. B. Dalvi, and E. A. Holly, “Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco Bay Area,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 7, pp. 1287–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  257. K. E. Smedby, H. Hjalgrim, E. T. Chang et al., “Childhood social environment and risk of non-Hodgkin lymphoma in adults,” Cancer Research, vol. 67, no. 22, pp. 11074–11082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  258. A. E. Grulich, C. M. Vajdic, M. O. Falster et al., “Birth order and risk of non-Hodgkin lymphoma—true association or bias?” American Journal of Epidemiology, vol. 172, no. 6, pp. 621–630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  259. A. Altieri, F. Castro, J. L. Bermejo, and K. Hemminki, “Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 7, pp. 1281–1286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  260. J. R. Cerhan, T. M. Habermann, C. M. Vachon et al., “Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa Women's Health Study (United States),” Cancer Causes and Control, vol. 13, no. 2, pp. 131–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  261. Y. Zhang, T. R. Holford, B. Leaderer et al., “Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among connecticut women,” American Journal of Epidemiology, vol. 160, no. 8, pp. 766–773, 2004. View at Publisher · View at Google Scholar · View at Scopus
  262. L. M. Morton, S. S. Wang, D. A. Richesson, A. Schatzkin, A. R. Hollenbeck, and J. V. Lacey, “Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort,” International Journal of Cancer, vol. 124, no. 11, pp. 2737–2743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  263. Y. Lu, S. S. Wang, J. Sullivan-Halley et al., “Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study,” International Journal of Cancer, vol. 129, no. 4, pp. 974–982, 2011. View at Publisher · View at Google Scholar · View at Scopus
  264. K. H. Mildon, P. Ansell, E. Roman, and E. V. Kane, “Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study,” Cancer Causes and Control, vol. 21, no. 12, pp. 2079–2083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  265. J. S. Lee, P. M. Bracci, and E. A. Holly, “Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use,” American Journal of Epidemiology, vol. 168, no. 3, pp. 278–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  266. E. V. Kane, E. Roman, N. Becker et al., “Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies,” Annals of Oncology, vol. 23, no. 9, pp. 2362–2374, 2012. View at Google Scholar
  267. L. Costas, D. Casabonne, Y. Benavente et al., “Reproductive factors and lymphoid neoplasms in Europe: findings from the EpiLymph case-control study,” Cancer Causes and Control, vol. 23, pp. 195–206, 2012. View at Google Scholar
  268. H. O. Adami, S. Tsaih, M. Lambe et al., “Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study,” International Journal of Cancer, vol. 70, pp. 155–158, 1997. View at Google Scholar
  269. J. Prescott, Y. Lu, E. T. Chang et al., “Reproductive factors and non-Hodgkin lymphoma risk in the California teachers study,” PLoS ONE, vol. 4, no. 12, Article ID e8135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  270. R. A. Nelson, A. M. Levine, and L. Bernstein, “Reproductive factors and risk of intermediate- or high-grade B-cell non-Hodgkin's lymphoma in women,” Journal of Clinical Oncology, vol. 19, no. 5, pp. 1381–1387, 2001. View at Google Scholar · View at Scopus
  271. E. Erber, U. Lim, G. Maskarinec, and L. N. Kolonel, “Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort,” International Journal of Cancer, vol. 125, no. 6, pp. 1440–1445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  272. J. R. Cerhan, R. B. Wallace, F. Dick et al., “Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia,” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 4, pp. 361–368, 2001. View at Google Scholar · View at Scopus
  273. J. R. Cerhan, R. B. Wallace, A. R. Folsom et al., “Medical history risk factors for non-Hodgkin's lymphoma in older women,” Journal of the National Cancer Institute, vol. 89, no. 4, pp. 314–318, 1997. View at Google Scholar · View at Scopus
  274. J. Adami, O. Nyrén, R. Bergström et al., “Blood transfusion and non-Hodgkin lymphoma: lack of association,” Annals of Internal Medicine, vol. 127, no. 5, pp. 365–371, 1997. View at Google Scholar · View at Scopus
  275. R. A. Nelson, A. M. Levine, and L. Bernstein, “Blood transfusions and the risk of intermediate- or high-grade non-Hodgkin's lymphoma,” Journal of the National Cancer Institute, vol. 90, no. 22, pp. 1742–1743, 1998. View at Google Scholar · View at Scopus
  276. E. K. Maguire-Boston, V. Suman, S. J. Jacobsen et al., “Blood transfusion and risk of non-Hodgkin's lymphoma,” American Journal of Epidemiology, vol. 149, no. 12, pp. 1113–1118, 1999. View at Google Scholar · View at Scopus
  277. Y. Zhang, T. R. Holford, B. Leaderer et al., “Blood transfusion and risk of non-Hodgkin's lymphoma in connecticut women,” American Journal of Epidemiology, vol. 160, no. 4, pp. 325–330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  278. E. J. Chow and E. A. Holly, “Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study,” American Journal of Epidemiology, vol. 155, no. 8, pp. 725–731, 2002. View at Publisher · View at Google Scholar · View at Scopus
  279. L. Brandt, J. Brandt, H. Olsson, H. Anderson, and T. Möller, “Blood transfusion as a risk factor for non-Hodgkin lymphoma,” British Journal of Cancer, vol. 73, no. 9, pp. 1148–1151, 1996. View at Google Scholar · View at Scopus
  280. J. J. Castillo, S. Dalia, and S. K. Pascual, “Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies,” Blood, vol. 116, no. 16, pp. 2897–2907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  281. J. O. Bordin and M. A. Blajchman, “Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy,” Hematology/Oncology Clinics of North America, vol. 9, no. 1, pp. 205–218, 1995. View at Google Scholar · View at Scopus
  282. J. R. Cerhan, “Transfusion and NHL risk: a meta-answer?” Blood, vol. 116, no. 16, pp. 2863–2864, 2010. View at Publisher · View at Google Scholar · View at Scopus
  283. Y. Jiang, P. J. Villeneuve, A. Wielgosz, D. E. Schaubel, S. S. A. Fenton, and Y. Mao, “The incidence of cancer in a population-based cohort of Canadian heart transplant recipients,” American Journal of Transplantation, vol. 10, no. 3, pp. 637–645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  284. J. Adami, H. Gäbel, B. Lindelöf et al., “Cancer risk following organ transplantation: a nationwide cohort study in Sweden,” British Journal of Cancer, vol. 89, no. 7, pp. 1221–1227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  285. S. C. Quinlan, R. M. Pfeiffer, L. M. Morton, and E. A. Engels, “Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States,” American Journal of Hematology, vol. 86, no. 2, pp. 206–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  286. R. J. Faull, P. Hollett, and S. P. McDonald, “Lymphoproliferative disease after renal transplantation in Australia and New Zealand,” Transplantation, vol. 80, no. 2, pp. 193–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  287. P. J. Villeneuve, D. E. Schaubel, S. S. Fenton, F. A. Shepherd, Y. Jiang, and Y. Mao, “Cancer incidence among Canadian kidney transplant recipients,” American Journal of Transplantation, vol. 7, no. 4, pp. 941–948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  288. J. Ying, P. J. Villeneuve, S. S. A. Fenton, D. E. Schaubel, L. Lilly, and M. Yang, “Liver transplantation and subsequent risk of Cancer: findings from a Canadian cohort study,” Liver Transplantation, vol. 14, no. 11, pp. 1588–1597, 2008. View at Publisher · View at Google Scholar · View at Scopus
  289. J. Fortuny, S. de Sanjosé, N. Becker et al., “Statin use and risk of lymphoid neoplasms: results from the European case-control study EPILYMPH,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 5, pp. 921–925, 2006. View at Publisher · View at Google Scholar · View at Scopus
  290. Y. Zhang, T. R. Holford, B. Leaderer et al., “Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in connecticut United States women,” Cancer Causes and Control, vol. 15, no. 4, pp. 419–428, 2004. View at Publisher · View at Google Scholar · View at Scopus
  291. C. Chao, L. Xu, D. I. Abrams et al., “HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons,” Acquired Immune Deficiency Syndrome, vol. 25, pp. 1771–1777, 2011. View at Google Scholar
  292. E. J. Jacobs, C. C. Newton, M. J. Thun, and S. M. Gapstur, “Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort,” Cancer Research, vol. 71, no. 5, pp. 1763–1771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  293. P. F. Coogan, L. Rosenberg, and B. L. Strom, “Statin use and the risk of 10 cancers,” Epidemiology, vol. 18, no. 2, pp. 213–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  294. K. Hindler, C. S. Cleeland, E. Rivera, and C. D. Collard, “The role of statins in cancer therapy,” Oncologist, vol. 11, no. 3, pp. 306–315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  295. J. R. Cerhan, K. E. Anderson, C. A. Janney, C. M. Vachon, T. E. Witzig, and T. M. Habermann, “Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma,” International Journal of Cancer, vol. 106, no. 5, pp. 784–788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  296. I. Kato, K. L. Koenig, R. E. Shore et al., “Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States),” Cancer Causes and Control, vol. 13, no. 10, pp. 965–974, 2002. View at Publisher · View at Google Scholar · View at Scopus
  297. M. L. Rasmussen, H. Hjalgrim, D. Molgaard-Nielsen, J. Wohlfahrt, and M. Melbye, “Antibiotic use and risk of non-Hodgkin lymphomas,” International Journal of Cancer, vol. 131, no. 7, pp. E1158–E1165, 2012. View at Google Scholar
  298. I. Kato, K. L. Koenig, M. S. Baptiste et al., “History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL),” International Journal of Cancer, vol. 107, no. 1, pp. 99–105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  299. E. T. Chang, K. E. Smedby, H. Hjalgrim et al., “Medication use and risk of non-Hodgkin's lymphoma,” American Journal of Epidemiology, vol. 162, no. 10, pp. 965–974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  300. S. Bernatsky, J. L. Lee, and E. Rahme, “Non-Hodgkin's lymphoma—meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories,” Rheumatology, vol. 46, no. 4, pp. 690–694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  301. J. A. Baker, J. R. Weiss, M. S. Czuczman, R. J. Menezes, C. B. Ambrosone, and K. B. Moysich, “Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma,” Cancer Causes and Control, vol. 16, no. 3, pp. 301–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  302. Y. Zhang, P. F. Coogan, J. R. Palmer, B. L. Strom, and L. Rosenberg, “Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs,” Cancer Detection and Prevention, vol. 30, no. 1, pp. 99–101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  303. E. D. Flick, K. A. Chan, P. M. Bracci, and E. A. Holly, “Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study,” American Journal of Epidemiology, vol. 164, no. 5, pp. 497–504, 2006. View at Publisher · View at Google Scholar · View at Scopus
  304. L. A. Anderson, G. Gridley, E. A. Engels et al., “Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study,” British Journal of Cancer, vol. 98, no. 1, pp. 161–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  305. A. B. Beiderbeck, E. A. Holly, M. C. J. M. Sturkenboom, J. W. W. Coebergh, B. H. C. Stricker, and H. G. M. Leufkens, “Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma,” American Journal of Epidemiology, vol. 157, no. 6, pp. 510–516, 2003. View at Publisher · View at Google Scholar · View at Scopus
  306. S. O. Dalton, A. H. Poulsen, M. Nørgaard, J. K. McLaughlin, C. Johansen, and S. Friis, “Tricyclic antidepressants and non-Hodgkin lymphoma,” Epidemiology, vol. 19, no. 4, pp. 546–549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  307. S. O. Dalton, C. Johansen, L. Mellemkjær et al., “Antidepressant medications and risk for cancer,” Epidemiology, vol. 11, no. 2, pp. 171–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  308. J. Stebbing, T. Powles, S. Mandalia, M. Nelson, B. Gazzard, and M. Bower, “Use of antidepressants and risk of cancer in individuals infected with HIV,” Journal of Clinical Oncology, vol. 26, no. 14, pp. 2305–2310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  309. S. Bahl, M. Cotterchio, N. Kreiger, and N. Klar, “Antidepressant medication use and non-Hodgkin's lymphoma risk: no association,” American Journal of Epidemiology, vol. 160, no. 6, pp. 566–575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  310. Y. Chen, T. Zheng, Q. Lan et al., “Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma,” Blood, vol. 117, no. 2, pp. 585–590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  311. L. M. Morton, L. Bernstein, S. S. Wang et al., “Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma,” Carcinogenesis, vol. 28, no. 8, pp. 1759–1764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  312. J. S. Colt, N. Rothman, R. K. Severson et al., “Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma,” Blood, vol. 113, no. 9, pp. 1899–1905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  313. X. Han, T. Zheng, Q. Lan et al., “Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 5, pp. 1429–1438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  314. K. H. Barry, Y. Zhang, Q. Lan et al., “Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-Hodgkin lymphoma,” American Journal of Epidemiology, vol. 173, no. 4, pp. 404–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  315. L. M. Morton, M. Schenk, D. W. Hein et al., “Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma,” Pharmacogenetics and Genomics, vol. 16, no. 8, pp. 537–545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  316. C. F. Skibola, J. D. Curry, and A. Nieters, “Genetic susceptibility to lymphoma,” Haematologica, vol. 92, no. 7, pp. 960–969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  317. N. Rothman, C. F. Skibola, S. S. Wang et al., “Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium,” Lancet Oncology, vol. 7, no. 1, pp. 27–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  318. C. F. Skibola, P. M. Bracci, A. Nieters et al., “Tumor necrosis factor (TNF) and lymphotoxin-α (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the interLymph consortium,” American Journal of Epidemiology, vol. 171, no. 3, pp. 267–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  319. K. E. Smedby, J. N. Foo, C. F. Skibola et al., “GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma,” PLoS Genetics, vol. 7, no. 4, Article ID e1001378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  320. C. F. Skibola, P. M. Bracci, E. Halperin et al., “Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma,” Nature Genetics, vol. 41, no. 8, pp. 873–875, 2009. View at Publisher · View at Google Scholar · View at Scopus
  321. L. Conde, E. Halperin, N. K. Akers et al., “Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32,” Nature Genetics, vol. 42, no. 8, pp. 661–664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  322. M. C. Di Bernardo, D. Crowther-Swanepoel, P. Broderick et al., “A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia,” Nature Genetics, vol. 40, no. 10, pp. 1204–1210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  323. D. Crowther-Swanepoel, P. Broderick, M. C. Di Bernardo et al., “Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk,” Nature Genetics, vol. 42, no. 2, pp. 132–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  324. S. L. Slager, K. G. Rabe, S. J. Achenbach et al., “Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL,” Blood, vol. 117, no. 6, pp. 1911–1916, 2011. View at Publisher · View at Google Scholar · View at Scopus
  325. D. Crowther-Swanepoel, M. C. Di Bernardo, K. Jamroziak et al., “Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk,” British Journal of Haematology, vol. 154, no. 2, pp. 229–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  326. D. Crowther-Swanepoel, M. Mansouri, A. Enjuanes et al., “Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk,” British Journal of Haematology, vol. 150, no. 4, pp. 473–479, 2010. View at Publisher · View at Google Scholar · View at Scopus